Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 AUD | 0.00% | -3.57% | +116.00% |
Business Summary
Number of employees: 2
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kilian Kelly
CEO | Chief Executive Officer | - | 14-02-28 |
Jolanta Airey
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-10 |
Suzanne Lipe
PRN | Corporate Officer/Principal | - | 19-05-19 |
Peter Webse
SEC | Corporate Secretary | 61 | 09-11-01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Wotton
BRD | Director/Board Member | 63 | 16-06-08 |
Geoff Brooke
CHM | Chairman | 68 | 19-05-19 |
Janine Rolfe
BRD | Director/Board Member | - | 22-08-31 |
Peter Webse
SEC | Corporate Secretary | 61 | 09-11-01 |
Darryl Maher
BRD | Director/Board Member | - | 20-06-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 179,631,786 | 151,873,098 ( 84.55 %) | 0 | 84.55 % |
Company contact information
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+116.00% | 32.2M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-1.11% | 21.97B | |
-5.20% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- CYP Stock
- Company Cynata Therapeutics Limited